Wise Medical (688580.SH) Reports 28.99% YoY Increase in H1 2021 Net Profit Attributable to Shareholders, Reaching RMB 69.18 Million

VISHEE (688580.SH) released its 2021 semi-annual report, reporting an operating revenue of RMB 191 million during the period, a year-on-year increase of 21.91%; net profit attributable to shareholders of the listed company was RMB 69.1816 million, up 28.99% year on year; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was RMB 57.6483 million, a year-on-year increase of 17.74%; and basic earnings per share was RMB 1.0122.

The announcement stated that the net profit attributable to shareholders of the listed company for the first half of 2021 was RMB 69.1816 million, representing a year-on-year increase of 28.99%, primarily attributable to the growth in sales revenue during the reporting period. Additionally, the after-tax impact of the share-based payment expense arising from the Company's implementation of the 《2021 Restricted Stock Incentive Plan》 was RMB 8.2291 million. Excluding the impact of the share-based payment expense, the net profit attributable to shareholders of the listed company for the first half of 2021 amounted to RMB 77.4107 million, up 44.33% year on year.